Steven L. Krill, EVP & Chief Scientific Officer at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 10,252 shares at $77.17 ($791K) on 2016-12-21, disclosed to the SEC on 2017-01-04.
Open-market sale of $791k EGRX by EVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.17 | 2,683 | $207K | 26.2% |
| 2 | $77.17 | 7,569 | $584K | 73.8% |
| Total | $77.17 avg | 10,252 | $791K | 100% |
| Filing → |
| EGRX | SELL | 2017-03-24 | $569K | — | Filing → |
| EGRX | SELL | 2017-01-04 | $756K | — | Filing → |
| EGRX | SELL | 2017-01-04 | $7.0M | — | Filing → |